Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
APT Pharmaceuticals
company
About
APT Pharmaceuticals is a drug-development company focused on treatments for significant unmet medical needs.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $22M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations.APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$54M
APT Pharmaceuticals has raised a total of
$54M
in funding over 2 rounds. Their latest funding was raised on
Sep 30, 2008 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 30, 2008 | Series B | $32M | 1 | — | — | Detail |
| Oct 5, 2007 | Series A | $22M | 1 |
Versant Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
APT Pharmaceuticals is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Versant Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
